-
1
-
-
84868550831
-
Inhibitors/antagonists of TGF-beta system in kidney fibrosis
-
Yanagita M. Inhibitors/antagonists of TGF-beta system in kidney fibrosis. Nephrol Dial Transplant 2012; 27: 3686-3691
-
(2012)
Nephrol Dial Transplant
, vol.27
, pp. 3686-3691
-
-
Yanagita, M.1
-
3
-
-
78049369136
-
Renal fibrosis: Novel insights into mechanisms and therapeutic targets
-
Boor P, Ostendorf T, Floege J. Renal fibrosis: novel insights into mechanisms and therapeutic targets. Nat Rev Nephrol 2010; 6: 643-656
-
(2010)
Nat Rev Nephrol
, vol.6
, pp. 643-656
-
-
Boor, P.1
Ostendorf, T.2
Floege, J.3
-
4
-
-
85047687511
-
Drug discovery in renal disease-towards a more efficient framework
-
Miyata T, Ando T, Hiragi H et al. Drug discovery in renal disease-towards a more efficient framework. Nat Rev Nephrol 2014; 10: 290-296
-
(2014)
Nat Rev Nephrol
, vol.10
, pp. 290-296
-
-
Miyata, T.1
Ando, T.2
Hiragi, H.3
-
5
-
-
34248207324
-
Biomarkers of liver fibrosis: Clinical translation of molecular pathogenesis or based on liver-dependent malfunction tests
-
Gressner OA, Weiskirchen R, Gressner AM. Biomarkers of liver fibrosis: clinical translation of molecular pathogenesis or based on liver-dependent malfunction tests. Clin Chim Acta 2007; 381: 107-113
-
(2007)
Clin Chim Acta
, vol.381
, pp. 107-113
-
-
Gressner, O.A.1
Weiskirchen, R.2
Gressner, A.M.3
-
6
-
-
84899155968
-
The extracellular matrix in the kidney: A source of novel non-invasive biomarkers of kidney fibrosis?
-
Genovese F, Manresa AA, Leeming DJ et al. The extracellular matrix in the kidney: a source of novel non-invasive biomarkers of kidney fibrosis? Fibrogenesis Tissue Repair 2014; 7: 4
-
(2014)
Fibrogenesis Tissue Repair
, vol.7
, pp. 4
-
-
Genovese, F.1
Manresa, A.A.2
Leeming, D.J.3
-
7
-
-
49449103020
-
Characterization of metalloprotease cleavage products of human articular cartilage
-
Zhen EY, Brittain IJ, Laska DA et al. Characterization of metalloprotease cleavage products of human articular cartilage. Arthritis Rheum 2008; 58: 2420-2431
-
(2008)
Arthritis Rheum
, vol.58
, pp. 2420-2431
-
-
Zhen, E.Y.1
Brittain, I.J.2
Laska, D.A.3
-
8
-
-
84861850705
-
Matrix metalloproteinases in kidney homeostasis and diseases
-
Tan RJ, Liu Y. Matrix metalloproteinases in kidney homeostasis and diseases. Am J Physiol Renal Physiol 2012; 302: F1351-F1361
-
(2012)
Am J Physiol Renal Physiol
, vol.302
, pp. F1351-F1361
-
-
Tan, R.J.1
Liu, Y.2
-
10
-
-
80054085615
-
Protein fingerprints-relying on and understanding the information of serological protein measurements
-
Karsdal MA, Delvin E, Christiansen C. Protein fingerprints-relying on and understanding the information of serological protein measurements. Clin Biochem 2011; 44: 1278-1279
-
(2011)
Clin Biochem
, vol.44
, pp. 1278-1279
-
-
Karsdal, M.A.1
Delvin, E.2
Christiansen, C.3
-
11
-
-
77953718011
-
A novel assay for extracellular matrix remodeling associated with liver fibrosis: An enzyme-linked immunosorbent assay (ELISA) for a MMP-9 proteolytically revealed neoepitope of type III collagen
-
Barascuk N, Veidal SS, Larsen L et al. A novel assay for extracellular matrix remodeling associated with liver fibrosis: an enzyme-linked immunosorbent assay (ELISA) for a MMP-9 proteolytically revealed neoepitope of type III collagen. Clin Biochem 2010; 43: 899-904
-
(2010)
Clin Biochem
, vol.43
, pp. 899-904
-
-
Barascuk, N.1
Veidal, S.S.2
Larsen, L.3
-
12
-
-
80054906939
-
A novel marker for assessment of liver matrix remodeling: An enzyme-linked immunosorbent assay (ELISA) detecting a MMP generated type i collagen neo-epitope (C1M)
-
Leeming D, He Y, Veidal S et al. A novel marker for assessment of liver matrix remodeling: an enzyme-linked immunosorbent assay (ELISA) detecting a MMP generated type I collagen neo-epitope (C1M). Biomarkers 2011; 16: 616-628
-
(2011)
Biomarkers
, vol.16
, pp. 616-628
-
-
Leeming, D.1
He, Y.2
Veidal, S.3
-
13
-
-
84899860592
-
Mesenchymal stem cells from rats with chronic kidney disease exhibit premature senescence and loss of regenerative potential
-
Klinkhammer BM, Kramann R, Mallau M et al. Mesenchymal stem cells from rats with chronic kidney disease exhibit premature senescence and loss of regenerative potential. PLoS ONE 2014; 9: e92115
-
(2014)
PLoS ONE
, vol.9
, pp. e92115
-
-
Klinkhammer, B.M.1
Kramann, R.2
Mallau, M.3
-
14
-
-
81155131056
-
The peroxisome proliferator-activated receptor-alpha agonist, BAY PP1, attenuates renal fibrosis in rats
-
Boor P, Celec P, Martin IV et al. The peroxisome proliferator-activated receptor-alpha agonist, BAY PP1, attenuates renal fibrosis in rats. Kidney Int 2011; 80: 1182-1197
-
(2011)
Kidney Int
, vol.80
, pp. 1182-1197
-
-
Boor, P.1
Celec, P.2
Martin, I.V.3
-
15
-
-
33645471300
-
Antagonism of PDGF-D by human antibody CR002 prevents renal scarring in experimental glomerulonephritis
-
Ostendorf T, Rong S, Boor P et al. Antagonism of PDGF-D by human antibody CR002 prevents renal scarring in experimental glomerulonephritis. J Am Soc Nephrol 2006; 17: 1054-1062
-
(2006)
J Am Soc Nephrol
, vol.17
, pp. 1054-1062
-
-
Ostendorf, T.1
Rong, S.2
Boor, P.3
-
16
-
-
34248154137
-
PDGF-D inhibition by CR002 ameliorates tubulointerstitial fibrosis following experimental glomerulonephritis
-
Boor P, Konieczny A, Villa L et al. PDGF-D inhibition by CR002 ameliorates tubulointerstitial fibrosis following experimental glomerulonephritis. Nephrol Dial Transplant 2007; 22: 1323-1331
-
(2007)
Nephrol Dial Transplant
, vol.22
, pp. 1323-1331
-
-
Boor, P.1
Konieczny, A.2
Villa, L.3
-
17
-
-
79251551113
-
Vascular calcification in chronic renal failure: What have we learned from animal studies?
-
Neven E, D'Haese PC. Vascular calcification in chronic renal failure: what have we learned from animal studies? Circ Res 2011; 108: 249-264
-
(2011)
Circ Res
, vol.108
, pp. 249-264
-
-
Neven, E.1
D'haese, P.C.2
-
18
-
-
0036208983
-
Expression of a novel PDGF isoform, PDGF-C, in normal and diseased rat kidney
-
Eitner F, Ostendorf T, Van Roeyen C et al. Expression of a novel PDGF isoform, PDGF-C, in normal and diseased rat kidney. J Am Soc Nephrol 2002; 13: 910-917
-
(2002)
J Am Soc Nephrol
, vol.13
, pp. 910-917
-
-
Eitner, F.1
Ostendorf, T.2
Van Roeyen, C.3
-
19
-
-
84877014403
-
The neo-epitope specific PRO-C3 ELISA measures true formation of type III collagen associated with liver and muscle parameters
-
Nielsen MJ, Nedergaard AF, Sun S et al. The neo-epitope specific PRO-C3 ELISA measures true formation of type III collagen associated with liver and muscle parameters. Am J Transl Res 2013; 5: 303-315
-
(2013)
Am J Transl Res
, vol.5
, pp. 303-315
-
-
Nielsen, M.J.1
Nedergaard, A.F.2
Sun, S.3
-
20
-
-
0033379998
-
Experimental mesangial proliferative glomerulonephritis (the anti-Thy-1. 1 model)
-
Jefferson JA, Johnson RJ. Experimental mesangial proliferative glomerulonephritis (the anti-Thy-1. 1 model). J Nephrol 1999; 12: 297-307
-
(1999)
J Nephrol
, vol.12
, pp. 297-307
-
-
Jefferson, J.A.1
Johnson, R.J.2
-
21
-
-
84875537194
-
Pathophysiology and treatment of focal segmental glomerulosclerosis: The role of animal models
-
de Mik SM, Hoogduijn MJ, de Bruin RW et al. Pathophysiology and treatment of focal segmental glomerulosclerosis: the role of animal models. BMC Nephrol 2013; 14: 74
-
(2013)
BMC Nephrol
, vol.14
, pp. 74
-
-
De Mik, S.M.1
Hoogduijn, M.J.2
De Bruin, R.W.3
-
22
-
-
0022449729
-
Animal model of adenine-induced chronic renal failure in rats
-
Yokozawa T, Zheng PD, Oura H et al. Animal model of adenine-induced chronic renal failure in rats. Nephron 1986; 44: 230-234
-
(1986)
Nephron
, vol.44
, pp. 230-234
-
-
Yokozawa, T.1
Zheng, P.D.2
Oura, H.3
-
23
-
-
77749328880
-
Urinary procollagen III aminoterminal propeptide (PIIINP): A fibrotest for the nephrologist
-
Ghoul BE, Squalli T, Servais A et al. Urinary procollagen III aminoterminal propeptide (PIIINP): a fibrotest for the nephrologist. Clin J Am Soc Nephrol 2010; 5: 205-210
-
(2010)
Clin J Am Soc Nephrol
, vol.5
, pp. 205-210
-
-
Ghoul, B.E.1
Squalli, T.2
Servais, A.3
-
24
-
-
0038789116
-
Urinary amino-terminal propeptide of type III procollagen (PIIINP) as a marker of interstitial fibrosis in renal transplant recipients
-
Teppo AM, Tornroth T, Honkanen E et al. Urinary amino-terminal propeptide of type III procollagen (PIIINP) as a marker of interstitial fibrosis in renal transplant recipients. Transplantation 2003; 75: 2113-2119
-
(2003)
Transplantation
, vol.75
, pp. 2113-2119
-
-
Teppo, A.M.1
Tornroth, T.2
Honkanen, E.3
-
25
-
-
80053195337
-
Association between markers of collagen turnover, arterial stiffness and left ventricular hypertrophy in chronic kidney disease (CKD): The Renal Research Institute (RRI)-CKD study
-
Dellegrottaglie S, Sands RL, Gillespie BW et al. Association between markers of collagen turnover, arterial stiffness and left ventricular hypertrophy in chronic kidney disease (CKD): the Renal Research Institute (RRI)-CKD study. Nephrol Dial Transplant 2011; 26: 2891-2898
-
(2011)
Nephrol Dial Transplant
, vol.26
, pp. 2891-2898
-
-
Dellegrottaglie, S.1
Sands, R.L.2
Gillespie, B.W.3
-
26
-
-
77958172541
-
Association between urinary type IV collagen level and deterioration of renal function in type 2 diabetic patients without overt proteinuria
-
Araki S, Haneda M, Koya D et al. Association between urinary type IV collagen level and deterioration of renal function in type 2 diabetic patients without overt proteinuria. Diabetes Care 2010; 33: 1805-1810
-
(2010)
Diabetes Care
, vol.33
, pp. 1805-1810
-
-
Araki, S.1
Haneda, M.2
Koya, D.3
-
27
-
-
0035003393
-
Urinary type IV collagen excretion reflects renal morphological alterations and type IV collagen expression in patients with type 2 diabetes mellitus
-
Okonogi H, Nishimura M, Utsunomiya Y et al. Urinary type IV collagen excretion reflects renal morphological alterations and type IV collagen expression in patients with type 2 diabetes mellitus. Clin Nephrol 2001; 55: 357-364
-
(2001)
Clin Nephrol
, vol.55
, pp. 357-364
-
-
Okonogi, H.1
Nishimura, M.2
Utsunomiya, Y.3
-
28
-
-
51849139372
-
Matrix metalloproteinases and matrix receptors in progression and reversal of kidney disease: Therapeutic perspectives
-
Ronco P, Chatziantoniou C. Matrix metalloproteinases and matrix receptors in progression and reversal of kidney disease: therapeutic perspectives. Kidney Int 2008; 74: 873-878
-
(2008)
Kidney Int
, vol.74
, pp. 873-878
-
-
Ronco, P.1
Chatziantoniou, C.2
-
29
-
-
77953706518
-
Novel combinations of posttranslational modification (PTM) neo-epitopes provide tissue-specific biochemical markers-are they the cause or the consequence of the disease?
-
Karsdal MA, Henriksen K, Leeming DJ et al. Novel combinations of posttranslational modification (PTM) neo-epitopes provide tissue-specific biochemical markers-are they the cause or the consequence of the disease? Clin Biochem 2010; 43: 793-804
-
(2010)
Clin Biochem
, vol.43
, pp. 793-804
-
-
Karsdal, M.A.1
Henriksen, K.2
Leeming, D.J.3
-
30
-
-
78349242472
-
Matrix metalloproteinase-9-mediated type III collagen degradation as a novel serological biochemical marker for liver fibrogenesis
-
Veidal SS, Vassiliadis E, Barascuk N et al. Matrix metalloproteinase-9-mediated type III collagen degradation as a novel serological biochemical marker for liver fibrogenesis. Liver Int 2010; 30: 1293-1304
-
(2010)
Liver Int
, vol.30
, pp. 1293-1304
-
-
Veidal, S.S.1
Vassiliadis, E.2
Barascuk, N.3
-
31
-
-
84884541673
-
Serum markers of the extracellular matrix remodeling reflect antifibrotic therapy in bile-duct ligated rats
-
Schierwagen R, Leeming DJ, Klein S et al. Serum markers of the extracellular matrix remodeling reflect antifibrotic therapy in bile-duct ligated rats. Front Physiol 2013; 4: 195
-
(2013)
Front Physiol
, vol.4
, pp. 195
-
-
Schierwagen, R.1
Leeming, D.J.2
Klein, S.3
-
32
-
-
79958242395
-
Measurement of CO3-610, a potential liver biomarker derived from matrix metalloproteinase-9 degradation of collagen type III, in a rat model of reversible carbon-tetrachlorideinduced fibrosis
-
Vassiliadis E, Larsen DV, Clausen RE et al. Measurement of CO3-610, a potential liver biomarker derived from matrix metalloproteinase-9 degradation of collagen type III, in a rat model of reversible carbon-tetrachlorideinduced fibrosis. Biomark Insights 2011; 6: 49-58
-
(2011)
Biomark Insights
, vol.6
, pp. 49-58
-
-
Vassiliadis, E.1
Larsen, D.V.2
Clausen, R.E.3
-
33
-
-
84885088369
-
Novel serological neo-epitope markers of extracellular matrix proteins for the detection of portal hypertension
-
Leeming DJ, Karsdal MA, Byrjalsen I et al. Novel serological neo-epitope markers of extracellular matrix proteins for the detection of portal hypertension. Aliment Pharmacol Ther 2013; 38: 1086-1096
-
(2013)
Aliment Pharmacol Ther
, vol.38
, pp. 1086-1096
-
-
Leeming, D.J.1
Karsdal, M.A.2
Byrjalsen, I.3
-
34
-
-
84887903585
-
Extracellular matrix specific protein fingerprints measured in serum can separate pancreatic cancer patients from healthy controls
-
Willumsen N, Bager CL, Leeming DJ et al. Extracellular matrix specific protein fingerprints measured in serum can separate pancreatic cancer patients from healthy controls. BMC Cancer 2013; 13: 554
-
(2013)
BMC Cancer
, vol.13
, pp. 554
-
-
Willumsen, N.1
Bager, C.L.2
Leeming, D.J.3
-
35
-
-
84866723961
-
Serological investigation of the collagen degradation profile of patients with chronic obstructive pulmonary disease or idiopathic pulmonary fibrosis
-
Leeming DJ, Sand JM, Nielsen MJ et al. Serological investigation of the collagen degradation profile of patients with chronic obstructive pulmonary disease or idiopathic pulmonary fibrosis. Biomark Insights 2012; 7: 119-126
-
(2012)
Biomark Insights
, vol.7
, pp. 119-126
-
-
Leeming, D.J.1
Sand, J.M.2
Nielsen, M.J.3
-
36
-
-
84878319474
-
Peptidyl arginine deiminase inhibitor effect on hepatic fibrogenesis in a CCl4 pre-clinical model of liver fibrosis
-
Vassiliadis E, Veidal SS, Kristiansen MN et al. Peptidyl arginine deiminase inhibitor effect on hepatic fibrogenesis in a CCl4 pre-clinical model of liver fibrosis. Am J Transl Res 2013; 5: 465-469
-
(2013)
Am J Transl Res
, vol.5
, pp. 465-469
-
-
Vassiliadis, E.1
Veidal, S.S.2
Kristiansen, M.N.3
-
37
-
-
84870328390
-
Urinary proteomics for early diagnosis in diabetic nephropathy
-
Zurbig P, Jerums G, Hovind P et al. Urinary proteomics for early diagnosis in diabetic nephropathy. Diabetes 2012; 61: 3304-3313
-
(2012)
Diabetes
, vol.61
, pp. 3304-3313
-
-
Zurbig, P.1
Jerums, G.2
Hovind, P.3
-
38
-
-
78149291420
-
Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease
-
Good DM, Zurbig P, Argiles A et al. Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease. Mol Cell Proteomics 2010; 9: 2424-2437
-
(2010)
Mol Cell Proteomics
, vol.9
, pp. 2424-2437
-
-
Good, D.M.1
Zurbig, P.2
Argiles, A.3
|